It was found that the combination of aspirin and sorafenib after inhibiting the expression of PFKFB3 can overcome the resistance of sorafenib by inducing apoptosis of HCC cells, so as to enhance the therapeutic effect of HCC (Li et al., 2017a). The gene discussed is PFKFB3; the disease is hepatocellular carcinoma.